The 3 references without contexts in paper E. Kunder V., M. Volkova V., I. Generalov I., G. Nevinsky A., Е. Кундер В., М. Волкова В., И. Генералов И., Г. Невинский А. (2014) “КЛИНИКО-ПАТОГЕНЕТИЧЕСКАЯ И ДИАГНОСТИЧЕСКАЯ ЗНАЧИМОСТЬ ДЕЗОКСИРИБОНУКЛЕАЗНОЙ АКТИВНОСТИ ПОЛИКЛОНАЛЬНЫХ IGG И СЫВОРОТКИ КРОВИ ПРИ СПОНДИЛОАРТРИТАХ // CLINICAL AND DIAGNOSTIC SIGNIFICANCE OF DEOXYRIBONUCLEASE ACTIVITY OF POLYCLONAL IgG AND BLOOD SERA IN PATIENTS WITH SPONDYLOARTHRITIS” / spz:neicon:mimmun:y:2012:i:5:p:337-346

15
Johnson S.R., Schentag C.T., Gladman D.D. Autoantibodies in biological agents nave patients with psoriatic arthritis // Ann. Rheum.Dis. – 2005. – Vol. 64. – P. 770-772.
(check this in PDF content)
23
Taylor W., Gladman D.D., Helliwell P., Marchesoni A., Mease P., Mielants H. CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study // Ann. Rheum. Dis. – 2006. – Vol. 54. – P. 2665-2673.
(check this in PDF content)
24
Linder S., Valkenburg H.A., Cat Valkenburgs A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria // Arthritis Rheum. – 1984. – Vol. 2. – P. 361-368.
(check this in PDF content)